Doctors boosting marijuana dosages

Mar 19, 2008

Canadian health officials say doctors are increasing the dosages of medical marijuana they prescribe for patients.

Health Canada said it appears doctors are unclear about the agency's maximum dosage recommendation. Some doctors said there was a perception the government's marijuana is not as potent as marijuana grown by patients or non-government suppliers, the Ottawa Citizen reported Tuesday.

The study by Les Etudes de marche Createc in Montreal found unanimous agreement among doctors for Health Canada to begin supplying dried marijuana to pharmacists. Doctors, however, suggested quality be improved and the price be reduced, the newspaper said.

Copyright 2008 by United Press International

Explore further: Determine patient preferences by means of conjoint analysis

add to favorites email to friend print save as pdf

Related Stories

Audi tests its A7 driverless vehicle on Florida highway

1 hour ago

German automaker Audi made use of a Florida law passed in 2012 that allows for testing driverless vehicles on Florida highways this past Sunday and Monday, by requesting a shutdown of Tampa's Lee Roy Selmon ...

India's Flipkart raises $1 bn to tackle Amazon

1 hour ago

India's top e-commerce company Flipkart said Tuesday it had raised $1 billion (60 billion rupees) in funds as it battles US giant Amazon for supremacy in the hyper-competitive local market.

Recommended for you

Determine patient preferences by means of conjoint analysis

4 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments : 0